Inter Partes Review and the Life Sciences
In Part IX of our series, we explored the use of inter partes review in the context of life sciences patents, including pharmaceuticals and diagnostics. We examined selected petitions filed to date involving life sciences patents. We also discussed strategic considerations and practice tips for both patent owners and challengers in this growing area.
Gwilym Attwell, Principal, Delaware